BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
April 20, 2011
View Archived Issues
Circassia Lands 3rd Largest Biotech Funding in Europe
LONDON – Circassia Ltd. claimed the third largest funding round by a European biotech in the past 15 years, raising £60 million (US$98 million) in a fourth round. (BioWorld International)
Read More
Actelion Readies for Ambush; Gets BB Biotech Backing
Read More
Fish Oil Drug Cuts Triglycerides in Second Phase III; NDA in 3Q
Read More
Potential $285M: Ipsen and Active Biotech in TASQ Deal
Read More
Insight into Antidepressant Action Yields Drug Target
Read More
4SC in $192M Agreement for Japan Rights to Resminostat
Read More
Galapagos Drops Its Lead Program in Rheumatoid Arthritis
Read More
Nabriva Gets Phase II Data for I.V. Pleuromutilin Antibiotic
Read More
Other News To Note
Read More